Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 536 participants.

Also called NCT03045562

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 536 participants (planned count) (from the registry)
Sponsor
Green Valley Group of China (from the registry)
Registry
  • NCT NCT03045562
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03045562. Randomized; quadruple masking; primary purpose treatment. Start 2017-01-20 (actual); primary completion 2018-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI
Acronym
SISTEMI
Condition
STEMI - ST Elevation Myocardial Infarction
Intervention (Drug)
Normal saline
Intervention (Drug)
Salvianolate injection
Lead sponsor
Green Valley Group of China (class: industry)

Record details

Record id
cardio:ct-nct03045562
Content hash
e36acff71acd1e09530d561f6d939072f8b3987e21226bea79b4a71f0f70e5c6